| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |